{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:53:30Z","timestamp":1791384810109,"version":"4.3.3"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Centro di Ricerca sulle Cellule Staminali Emopoietiche e le Terapie Cellulari, Universit\u00e0 Cattolica del Sacro Cuore in Rome","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00277-018-3535-y","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T18:39:25Z","timestamp":1541097565000},"page":"1495-1497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience"],"prefix":"10.1007","volume":"98","author":[{"given":"Elisabetta","family":"Metafuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Spanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"3535_CR1","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00277-018-3341-6","volume":"97","author":"C Cattaneo","year":"2018","unstructured":"Cattaneo C, Di Blasi R, Skert C, Candoni A, Martino B, Di Renzo N, Delia M, Ballanti S, Marchesi F, Mancini V, Orciuolo E, Cesaro S, Prezioso L, Fanci R, Nadali G, Chierichini A, Facchini L, Picardi M, Malagola M, Orlando V, Trecarichi EM, Tumbarello M, Aversa F, Rossi G, Pagano L, SEIFEM Group (2018) Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol 97:1717\u20131726. \n                    https:\/\/doi.org\/10.1007\/s00277-018-3341-6","journal-title":"Ann Hematol"},{"issue":"4","key":"3535_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"EM Trecarichi","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, Nosari A, Caira M, Spadea A, Busca A, Vianelli N, Tumbarello M, HeMABIS Registry\u2014SEIFEM Group, Italy (2015) Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect 21(4):337\u2013343. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2014.11.022","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"3535_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","volume":"23","author":"H Wright","year":"2017","unstructured":"Wright H, Bonomo RA, Paterson DL (2017) New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn? Clin Microbiol Infect 23(10):704\u2013712. Review. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2017.09.001","journal-title":"Clin Microbiol Infect"},{"key":"3535_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijid.2017.03.021","volume":"59","author":"JJ Cast\u00f3n","year":"2017","unstructured":"Cast\u00f3n JJ, Lacort-Peralta I, Mart\u00edn-D\u00e1vila P, Loeches B, Tabares S, Temkin L, Torre-Cisneros J, Pa\u00f1o-Pardo JR (2017) Clinical efficacy of ceftazidime\/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients. Int J Infect Dis 59:118\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2017.03.021","journal-title":"Int J Infect Dis"},{"issue":"6","key":"3535_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","volume":"16","author":"Y Carmeli","year":"2016","unstructured":"Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB (2016) Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis 16(6):661\u2013673. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(16)30004-4","journal-title":"Lancet Infect Dis"},{"key":"3535_CR6","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2017). Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017. \n                    http:\/\/www.eucast.org"},{"key":"3535_CR7","unstructured":"Zavicefta\u00ae.\n                    http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/004027\/human_med_001993.jsp&mid=WC0b01ac058001d124"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3535-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3535-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3535-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T10:24:40Z","timestamp":1572603880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3535-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3535-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"19 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}